Open company graph database — free web & API
Login

Astellas Pharma Ltd.

Astellas Pharma s.r.o.Astellas Pharma Inc.Aliasアステラス製薬Alias
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
11
§01

Basic information

BASIC
Head office
Tokyo
Chief executive
Okamura
Capital
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

10
Products and Disease AreasRx+ Business CreationDigital Transformation (DX)HealthXCancer TreatmentEye and Urology Disease TreatmentImmunotherapyWomen's Health TreatmentResearch and Development ProgramHealthcare Solution Development
§04

Related companies

11 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón
Alliance
La Asociación de Cáncer de Próstata (ANCAP)
Alliance
Plataforma de Organizaciones de Pacientes
Alliance
The European Kidney Patients’ Federation
Alliance
The European Patients’ Forum
Alliance
The United Mitochondrial Disease Foundation
Alliance
Avara Norman Pharmaceutical Services, Inc.
Nichi Iko Co., Ltd.
Takeda Tebafa Pharma Co., Ltd.
Takeda Teba Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Company, Limited
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

9 EVENTS

Fujisawa Pharmaceutical Industry was established in 1894.Sources

Yamanouchi Pharmaceutical was established in 1923.Sources

Renamed to Yamanouchi Pharmaceutical Co., Ltd. in 1940.Sources

Headquarters were relocated to Tokyo in 1942.Sources

Astellas was established in April 2005 through the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical.Sources

Astellas was established in April 2005 through the merger of Yamanouchi Pharmaceutical (founded in 1923) and Fujisawa Pharmaceutical (founded in 1894). Leaders from Yamanouchi and Fujisawa shake hands, marking the 2005 merger that formed Astellas and shaped a patient-first global strategy.Sources

Leaders from Yamanouchi and Fujisawa shake hands, marking the 2005 merger that formed Astellas and shaped a patient-first global strategy. Astellas was established in April 2005 through the merger of two companies – Yamanouchi Pharmaceutical (founded in 1923) and Fujisawa Pharmaceutical (founded in 1894).Sources

Astellas Pharmaceutical celebrated its 20th anniversary in April 2025.Sources

In April 2025, Astellas celebrated our 20th Anniversary as a company.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑